Kegeles LS - Search Results

1

Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.

Merritt K, McCutcheon RA, Aleman A, Ashley S, Beck K, Block W, Bloemen OJN, Borgan F, Boules C, Bustillo JR, Capizzano AA, Coughlin JM, David A, de la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, Du F, Falkai P, Galińska-Skok B, Gallinat J, Gasparovic C, Ginestet CE, Goto N, Graff-Guerrero A, Ho BC, Howes O, Jauhar S, Jeon P, Kato T, Kaufmann CA, Kegeles LS, Keshavan MS, Kim SY, King B, Kunugi H, Lauriello J, León-Ortiz P, Liemburg E, Mcilwain ME, Modinos G, Mouchlianitis E, Nakamura J, Nenadic I, Öngür D, Ota M, Palaniyappan L, Pantelis C, Patel T, Plitman E, Posporelis S, Purdon SE, Reichenbach JR, Renshaw PF, Reyes-Madrigal F, Russell BR, Sawa A, Schaefer M, Shungu DC, Smesny S, Stanley JA, Stone J, Szulc A, Taylor R, Thakkar KN, Théberge J, Tibbo PG, van Amelsvoort T, Walecki J, Williamson PC, Wood SJ, Xin L, Yamasue H, McGuire P, Egerton A; 1H-MRS in Schizophrenia Investigators. Merritt K, et al. Among authors: kegeles ls. Mol Psychiatry. 2023 May;28(5):2039-2048. doi: 10.1038/s41380-023-01991-7. Epub 2023 Feb 17. Mol Psychiatry. 2023. PMID: 36806762 Free PMC article.

2

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.

Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M. Martinez D, et al. Neuropsychopharmacology. 2001 May;24(5):553-60. doi: 10.1016/S0893-133X(00)00216-5. Neuropsychopharmacology. 2001. PMID: 11282255

3

Organ perfusion by dynamic scintigraphy convection-diffusion tracer kinetics in a phantom.

Kegeles LS, Stritzke P, Kupfer S, Vallabhajosula S, Burrows L, Schanzer H, Goldsmith SJ. Kegeles LS, et al. Am J Physiol. 1992 Nov;263(5 Pt 2):F963-73. doi: 10.1152/ajprenal.1992.263.5.F963. Am J Physiol. 1992. PMID: 1443185

4

In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.

Narendran R, Hwang DR, Slifstein M, Talbot PS, Erritzoe D, Huang Y, Cooper TB, Martinez D, Kegeles LS, Abi-Dargham A, Laruelle M. Narendran R, et al. Among authors: kegeles ls. Synapse. 2004 Jun 1;52(3):188-208. doi: 10.1002/syn.20013. Synapse. 2004. PMID: 15065219

5

(-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors.

Hwang DR, Kegeles LS, Laruelle M. Hwang DR, et al. Among authors: kegeles ls. Nucl Med Biol. 2000 Aug;27(6):533-9. doi: 10.1016/s0969-8051(00)00144-x. Nucl Med Biol. 2000. PMID: 11056366 Free article.

6

Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.

Huang Y, Hwang DR, Narendran R, Sudo Y, Chatterjee R, Bae SA, Mawlawi O, Kegeles LS, Wilson AA, Kung HF, Laruelle M. Huang Y, et al. Among authors: kegeles ls. J Cereb Blood Flow Metab. 2002 Nov;22(11):1377-98. doi: 10.1097/01.WCB.0000040948.67415.05. J Cereb Blood Flow Metab. 2002. PMID: 12439295

7

Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.

Huang Y, Kegeles LS, Bae S, Hwang D, Roth BL, Savage JE, Laruelle M. Huang Y, et al. Among authors: kegeles ls. Bioorg Med Chem Lett. 2001 Jun 4;11(11):1375-7. doi: 10.1016/s0960-894x(01)00241-4. Bioorg Med Chem Lett. 2001. PMID: 11378358

8

NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.

Kegeles LS, Martinez D, Kochan LD, Hwang DR, Huang Y, Mawlawi O, Suckow RF, Van Heertum RL, Laruelle M. Kegeles LS, et al. Synapse. 2002 Jan;43(1):19-29. doi: 10.1002/syn.10010. Synapse. 2002. PMID: 11746730

9

Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates.

Hwang DR, Narendran R, Huang Y, Slifstein M, Talbot PS, Sudo Y, Van Berckel BN, Kegeles LS, Martinez D, Laruelle M. Hwang DR, et al. Among authors: kegeles ls. J Nucl Med. 2004 Feb;45(2):338-46. J Nucl Med. 2004. PMID: 14960658 Free article.

10

Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).

Huang Y, Hwang DR, Zhu Z, Bae SA, Guo N, Sudo Y, Kegeles LS, Laruelle M. Huang Y, et al. Among authors: kegeles ls. Nucl Med Biol. 2002 Oct;29(7):741-51. doi: 10.1016/s0969-8051(02)00337-2. Nucl Med Biol. 2002. PMID: 12381454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page